Fuzzy Pet Health vs Amgen
Side-by-side comparison of AI visibility scores, market position, and capabilities
San Francisco subscription pet health platform with 24/7 vet access and prescription delivery; licensed vets handle behavioral issues, chronic conditions, and medication refills remotely.
About
Fuzzy Pet Health is a San Francisco-based pet health company that offers subscription-based veterinary care for dogs and cats, combining 24/7 text-based and video access to licensed veterinarians with physical product delivery including medications, supplements, and health supplies. The membership model eliminates the friction of scheduling in-person vet visits for non-emergency questions, behavioral concerns, and prescription refills, making routine pet care more accessible and affordable for urban pet owners. Fuzzy's licensed veterinary team can assess symptoms, recommend treatment, write prescriptions, and ship medications directly to members' doors within the membership price, reducing out-of-pocket spending on routine care.
Amgen (AMGN) reported $33.4B revenue in FY2024, up 19% YoY (post-Horizon acquisition). Top-5 global biotech. 10+ blockbuster drugs. ~24,000 employees. HQ: Thousand Oaks, CA. Market cap ~$130B.
About
Amgen Inc. is one of the world's largest biotechnology companies, headquartered in Thousand Oaks, California. Founded in 1980 as Applied Molecular Genetics, Amgen pioneered the development of biologics and brought landmark medicines including Epogen, Neupogen, and Enbrel to market. The company reported revenues of $33.4B in FY2024, up 19% year-over-year, boosted by the transformational $28B acquisition of Horizon Therapeutics in October 2023.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.